FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138307308> ?p ?o ?g. }

• W3138307308 abstract "Introduction: Cholangiocarcinoma (CCA) is the second most common primary tumor of the liver, and the recurrence after hepatic resection (HR), the only curative therapy, is linked with a worse prognosis. Systemic chemotherapy (SC) and liver loco-regional treatments, like trans-arterial chemoembolization (TACE) or radio embolization (TARE), have been employed for the treatment of unresectable intrahepatic metastasis (IM) with benefit on overall survival (OS), but SC has a limited effect on peritoneal metastasis (PM). In the last years, novel treatments like electrochemotherapy (ECT) with bleomycine (BLM) for IM and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS and HIPEC) for PM have been applied in small series but with encouraging results. We hereby describe the first synchronous application of ECT and CRS and HIPEC for the treatment of a patient with IM and PM from CCA. Case Description: A 47-year-old male patient with CCA underwent HR followed by adjuvant SC. After 14 months, for the occurrence of IM, the patient underwent a second HR and SC. Nonetheless, a new recurrence occurred and a third attempt of HR was proposed. Due to the intraoperative finding of unresectable IM with PM, no resective procedure was performed and the patient was referred to our center. CRS and HIPEC with cisplatin and mitomycin for PM and ECT with BLM on a bulky metastasis of the hepatic hilum were performed after 38 months from the first HR. The length of hospital stay was 19 days. At the computed tomography (CT) performed 11 days after treatment complete necrosis of the treated IM was detected. Results: CT scan after 3 and 6 months and magnetic resonance after 9 months were performed. Necrosis of the treated IM nor PM but progression of the residual liver lesions was observed. After 3 months, the patient received SC and underwent TACE after 8 months and TARE after 9 months for the residual liver metastases. At 14 months from CRS and HIPEC, the patient is alive, in good condition, and with stability of the disease. Conclusions: The association of ECT and CRS and HIPEC could be safe and effective for the treatment of unresectable recurrent intrahepatic CCA with PM." @default.
• W3138307308 created "2021-03-29" @default.
• W3138307308 creator A5001859631 @default.
• W3138307308 creator A5010581680 @default.
• W3138307308 creator A5019166100 @default.
• W3138307308 creator A5020618737 @default.
• W3138307308 creator A5026711643 @default.
• W3138307308 creator A5047660772 @default.
• W3138307308 creator A5053975661 @default.
• W3138307308 creator A5058780088 @default.
• W3138307308 creator A5060234029 @default.
• W3138307308 creator A5062091072 @default.
• W3138307308 creator A5077313738 @default.
• W3138307308 creator A5084824536 @default.
• W3138307308 date "2021-03-19" @default.
• W3138307308 modified "2023-10-18" @default.
• W3138307308 title "Case Report: Cytoreductive Surgery and HIPEC Associated With Liver Electrochemotherapy in a Cholangiocarcinoma Patient With Peritoneal Carcinomatosis and Liver Metastasis Case Report" @default.
• W3138307308 cites W1918457830 @default.
• W3138307308 cites W1942118595 @default.
• W3138307308 cites W1970207102 @default.
• W3138307308 cites W1970938197 @default.
• W3138307308 cites W1980595140 @default.
• W3138307308 cites W1981579055 @default.
• W3138307308 cites W1982209707 @default.
• W3138307308 cites W1993180801 @default.
• W3138307308 cites W2051099595 @default.
• W3138307308 cites W2052001271 @default.
• W3138307308 cites W2053336269 @default.
• W3138307308 cites W2061256992 @default.
• W3138307308 cites W2085618369 @default.
• W3138307308 cites W2098904191 @default.
• W3138307308 cites W2118698732 @default.
• W3138307308 cites W2139937737 @default.
• W3138307308 cites W2141078344 @default.
• W3138307308 cites W2153387653 @default.
• W3138307308 cites W2167670081 @default.
• W3138307308 cites W2170008162 @default.
• W3138307308 cites W2393656963 @default.
• W3138307308 cites W2603796126 @default.
• W3138307308 cites W2610585226 @default.
• W3138307308 cites W2752677305 @default.
• W3138307308 cites W2771927563 @default.
• W3138307308 cites W2784597821 @default.
• W3138307308 cites W2790664553 @default.
• W3138307308 cites W2809643616 @default.
• W3138307308 cites W2815603236 @default.
• W3138307308 cites W2873595960 @default.
• W3138307308 cites W2921715564 @default.
• W3138307308 cites W2973596517 @default.
• W3138307308 cites W2981729733 @default.
• W3138307308 cites W3000350486 @default.
• W3138307308 cites W9145604 @default.
• W3138307308 doi "https://doi.org/10.3389/fsurg.2021.624817" @default.
• W3138307308 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8018578" @default.
• W3138307308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33816544" @default.
• W3138307308 hasPublicationYear "2021" @default.
• W3138307308 type Work @default.
• W3138307308 sameAs 3138307308 @default.
• W3138307308 citedByCount "3" @default.
• W3138307308 countsByYear W31383073082022 @default.
• W3138307308 countsByYear W31383073082023 @default.
• W3138307308 crossrefType "journal-article" @default.
• W3138307308 hasAuthorship W3138307308A5001859631 @default.
• W3138307308 hasAuthorship W3138307308A5010581680 @default.
• W3138307308 hasAuthorship W3138307308A5019166100 @default.
• W3138307308 hasAuthorship W3138307308A5020618737 @default.
• W3138307308 hasAuthorship W3138307308A5026711643 @default.
• W3138307308 hasAuthorship W3138307308A5047660772 @default.
• W3138307308 hasAuthorship W3138307308A5053975661 @default.
• W3138307308 hasAuthorship W3138307308A5058780088 @default.
• W3138307308 hasAuthorship W3138307308A5060234029 @default.
• W3138307308 hasAuthorship W3138307308A5062091072 @default.
• W3138307308 hasAuthorship W3138307308A5077313738 @default.
• W3138307308 hasAuthorship W3138307308A5084824536 @default.
• W3138307308 hasBestOaLocation W31383073081 @default.
• W3138307308 hasConcept C121608353 @default.
• W3138307308 hasConcept C126322002 @default.
• W3138307308 hasConcept C126838900 @default.
• W3138307308 hasConcept C141071460 @default.
• W3138307308 hasConcept C2779013556 @default.
• W3138307308 hasConcept C2779338040 @default.
• W3138307308 hasConcept C2779458272 @default.
• W3138307308 hasConcept C2779819216 @default.
• W3138307308 hasConcept C2780427987 @default.
• W3138307308 hasConcept C2909135397 @default.
• W3138307308 hasConcept C2994223192 @default.
• W3138307308 hasConcept C71924100 @default.
• W3138307308 hasConceptScore W3138307308C121608353 @default.
• W3138307308 hasConceptScore W3138307308C126322002 @default.
• W3138307308 hasConceptScore W3138307308C126838900 @default.
• W3138307308 hasConceptScore W3138307308C141071460 @default.
• W3138307308 hasConceptScore W3138307308C2779013556 @default.
• W3138307308 hasConceptScore W3138307308C2779338040 @default.
• W3138307308 hasConceptScore W3138307308C2779458272 @default.
• W3138307308 hasConceptScore W3138307308C2779819216 @default.
• W3138307308 hasConceptScore W3138307308C2780427987 @default.
• W3138307308 hasConceptScore W3138307308C2909135397 @default.
• W3138307308 hasConceptScore W3138307308C2994223192 @default.
• W3138307308 hasConceptScore W3138307308C71924100 @default.
• W3138307308 hasLocation W31383073081 @default.

• next